🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, multicentre, randomised phase II trial in relapsed o...
Status
Active Not Recruiting
Location
The Beatson West of Scotland Cancer Centre
Start Date
2022-06-27
Trial ID
NCT05221645
Treatments Being Tested
This randomized phase III trial studies rituximab when given together with ...
Status
Completed
Location
Rebecca and John Moores UCSD Cancer Center
Start Date
2005-05
Trial ID
NCT00118209
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Unknown
Location
St. Anna Children's Hospital
Start Date
2006-06
Trial ID
NCT00379457
This is a Phase III, randomized, double-blind, placebo-controlled, multi-ce...
Status
Completed
Location
Research Site
Start Date
2018-03-29
Trial ID
NCT03519971
This randomized phase II/III trial investigates the antileukemic activity a...
Status
Unknown
Location
Hannover Medical School
Start Date
1999-01
Trial ID
NCT00209833
Treatments Being Tested
RATIONALE: Giving chemotherapy before an autologous stem cell transplant st...
Status
Unknown
Location
Kinderklinik - Universitaetsklinikum Aachen
Start Date
2007-01
Trial ID
NCT00526318
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Terminated
Location
U.Z. Gasthuisberg
Start Date
2003-03
Trial ID
NCT00060385
In this study, the XNW5004 tablets combined with CHOP/CHOEP will be used fo...
Status
Recruiting
Location
Shanghai Cancer Center
Start Date
2025-08-15
Trial ID
NCT07730515
The objective of this protocol is to improve survival for adults with acute...
Status
Terminated
Location
UCSD, Division of Blood and Marrow Transplantation, Moores Cancer Center
Start Date
2014-01
Trial ID
NCT02043587
Treatments Being Tested
At this point in the treatment of extensive stage SCLC, we have reached a p...
Status
Completed
Location
Helen F. Graham Cancer Center
Start Date
2008-01
Trial ID
NCT00613626